Today's episode of the PGX for Pharmacists podcast is hosted by Dr. Becky Winslow, PharmD. Dr. Winslow is a pharmacogenomics authority with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. 

Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels.  He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor at the University of South Florida Taneja College of Pharmacy.  Howard received a BSPharm from University of Washington and a PharmD from the Philadelphia College of Pharmacy & Science. 

Dr. McLeod completed clinical pharmacology fellowship training at St Jude Children’s Research Hospital and then the Beatson Institute, University of Glasgow.  Dr McLeod has been a tenured full Professor since 2002 and involved in over $80,000,000 in peer reviewed funding. 

Dr McLeod chaired the NHGRI eMERGE network external scientific panel for the past decade and was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council.  Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy and was recently ranked #1 USA/#2 World for Pharmacogenomics.  He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies. 

Howard has published over 580 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare.

This episode of the PGX for Pharmacist podcast is sponsored by Pharmazam: 

https://pharmazam.com/PPN